Search
Search Results
##search.searchResults.foundPlural##
-
IRON DEFICIENCY ANAEMIA AMONG PRE-SCHOOL CHILDREN WITH SICKLE CELL ANAEMIA: STILL A RARE DIAGNOSIS?
1494PDF: 860HTML: 2942cover leer: 166 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
520PDF: 570Suppl. Files: 68HTML: 159 -
-
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1920PDF: 878HTML: 1641 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2102PDF: 840HTML: 1226 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2787PDF: 989HTML: 633 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2570PDF: 984HTML: 2252 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1534PDF: 1007HTML: 512 -
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1414PDF: 1078HTML: 4670 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3359PDF: 1754HTML: 1167 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
850PDF: 565HTML: 4031 -
-
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2286PDF: 1481HTML: 971 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2353PDF: 948HTML: 2225 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1482PDF: 963HTML: 253 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2667PDF: 843HTML: 5377 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1677PDF: 597HTML: 893 -
Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
2313PDF: 822HTML: 902Figure 2: 233Figure 1: 191 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1219PDF: 862Html: 198 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1635PDF: 879HTML: 1081Picture 1: 190 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1309PDF: 547HTML: 23155 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2503PDF: 1022HTML: 413Supplementary table 1: 240Some of the mutation detection samples: 243 -
PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA
2519PDF: 1275HTML: 4857table: 229fig 1: 247fig 2: 195 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4380PDF: 1566HTML: 470 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
1194PDF: 880HTML: 602 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2657PDF: 977HTML: 594 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1364PDF: 1084HTML: 429 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1698PDF: 945HTML: 3194Figure 5: 175Figure 4: 174Figure 3: 209Figure 1: 189Figure 2: 188







